Clinical Trial Update: Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Tenecteplase reperfusion therapy for acute ischemic stroke (TRACE) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED